School of Medicine

A study by researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

With a goal of developing rheumatoid arthritis therapies with minimal side effects, School of Medicine researchers have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

A study led by Washington University School of Medicine, in collaboration with the Special School District of St. Louis County, found that rapid saliva test screenings contributed to exceedingly low transmission of the virus that causes COVID-19 among students, teachers and staff in those schools.

A new analysis from Washington University School of Medicine suggests that the St. Louis region avoided thousands of hospitalizations and deaths with early and coordinated public health measures as the COVID-19 pandemic was first taking hold.

Bo Zhang, at the School of Medicine, received a five-year $1.89 million Maximizing Investigators’ Research Award from the National Institutes of Health (NIH) for a research project involving the human genome.

Two studies led by Washington University School of Medicine describe the potential of liquid biopsies to identify and track tumor growth in bladder cancer and peripheral nerve tumors. The studies demonstrate the possible benefits of this relatively new tool in the fight against cancer.

New research from Washington University School of Medicine suggests that in-home falls can be reduced by nearly 40% with a community-based program that helps older adults make modifications to their homes to prevent such mishaps.

Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a study by researchers at Washington University School of Medicine.

Deborah Veis, MD, PhD, professor of medicine in the Division of Bone and Mineral Diseases at the School of Medicine, has been appointed the next editor-in-chief of the Journal of Bone and Mineral Research Plus. Her five-year term begins Sept. 1.

A team from the McKelvey School of Engineering and the School of Medicine will use a $3.12 million grant to improve brain imaging to better understand stroke recovery.